Free Radiation Oncology CME 2017‑2018 | CMEList.com

 


Updates in Lung Cancer: Targeting Epidermal Growth Factor Receptor
Live online September 7, 2016, and available on demand through March 7, 2017.
Posted by...Bernard Sklar, MD.Lung Cancer CME
Free Lung Cancer CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, oncology nurses, nurse practitioners, physician assistants, internists, primary care physicians, pulmonologists, and other health care professionals who treat patients with lung cancer.
Educational material updated... September 7, 2016.
Expiration of CME credit... March 7, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc.
Updates in Lung Cancer: Targeting Epidermal Growth Factor Receptor consists of a single lecture:
• Updates in Lung Cancer: Targeting Epidermal Growth Factor Receptor
At the conclusion of Updates in Lung Cancer, you will be able to:
• Review the pathophysiology of NSCLC and the role played by EGFR and activating EGFR mutations
• Provide the rationale for EGFR mutation testing to identify appropriate patients for targeted therapy
• Evaluate currently approved EGFR inhibitors and their role in the treatment of NSCLC
• Discuss the adverse events common to this drug class and how individual drugs might differ, and present management strategies

Updates in Lung Cancer: ALK Inhibition in the Treatment of NSCLC Free Pulmonary CME
Live online September 7, 2016, and available on demand through March 7, 2016.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, radiation oncologists, lung surgeons, fellows and other health care professionals (primary care physicians, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with lung cancer.
Educational material updated...September 7, 2016.
Expiration of CME credit... March 7, 2016.
Financial Support...Ariad Pharmaceuticals, Inc.
At the conclusion of Updates in Lung Cancer: ALK Inhibition in the Treatment of NSCLC, you will be able to:
• Provide rationale for testing for ALK mutations and use of ALK inhibitors
• Evaluate latest clinical data on new and emerging ALK inhibitors and combinations for use in patients with NSCLC
• Manage resistance to ALK inhibitors with appropriate second-line options

HER2+ BRCA INSTANT SYMPOSIUM: Updates on HER2 Positive Breast Cancer Management Free Breast Cancer CME
Live online June 10, 2016, and available on demand through June 10, 2017.
Posted by...Bernard Sklar, MD.
Free Breast Cancer CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, hematologist-oncologists, radiation oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other healthcare professionals who treat patients with breast cancer.
Educational material updated...June 10, 2016.
Expiration of CME credit...June 10, 2017.
Financial Support...Genentech.
Updates on HER2 Positive Breast Cancer Management consists of a single lecture with discussion:
Updates on HER2 Positive Breast Cancer Management
At the conclusion of Updates on HER2 Positive Breast Cancer Management, you will be able to:
• Summarize the efficacy and safety of new and emerging treatment approaches for HER2 positive breast cancer in the neoadjuvant, adjuvant and metastatic settings
• Evaluate therapeutic challenges associated with HER2-targeted treatment, including resistance, toxicity and optimal duration of treatment